Global Congress on Obesity, Diabetes and Metabolic Health
June 15-16, 2026 Paris, France
"One World, One Mission: Tackling Obesity, Diabetes & Metabolic Disease"
About Global Congress on Obesity, Diabetes and Metabolic Health
Elevate Your Career — Attend the Conference to Secure Your CPD Credits
The Global Congress on Obesity, Diabetes and Metabolic Health(ODMH Con 2026) is a premier international event scheduled to be held on June 15-16, 2026 at Paris, France dedicated to advancing research, treatment, and prevention strategies for some of today’s most widespread chronic conditions. Over two days, experts from around the world will gather to share groundbreaking discoveries, innovative therapies, and evidence-based best practices. The conference provides a dynamic platform for multidisciplinary collaboration, bridging the gap between laboratory science, clinical care, and public health initiatives. Participants will engage in keynote presentations, panel discussions, and interactive workshops designed to foster knowledge exchange and inspire new approaches to tackling metabolic health challenges.
Hosted in the vibrant city of Paris, this congress offers a unique blend of scientific excellence and cultural richness. Attendees will benefit from networking opportunities with leading clinicians, researchers, policymakers, and industry innovators. The event emphasizes translating scientific insights into practical solutions that can improve patient outcomes and inform health policies globally. By fostering a holistic understanding of obesity, diabetes, and metabolic health, the congress aims to empower healthcare professionals and stakeholders to drive meaningful change and enhance the quality of life for affected populations worldwide.
Vision and Purpose
This congress seeks to accelerate the understanding, prevention, and management of obesity, diabetes, and metabolic health disorders by fostering collaboration across disciplines and borders. The purpose is to bridge research and clinical practice, promote innovative therapies, and highlight public health initiatives to combat these global health challenges.
Who Attends
- Endocrinologists and Diabetologists
- Obesity Specialists and Nutritionists
- Researchers and Academicians
- Primary Care Physicians and Healthcare Providers
- Policy Makers and Public Health Experts
- Pharmaceutical and Medical Device Industry Professionals
- Students and Trainees
Why It Matters
Obesity, diabetes, and metabolic disorders are among the most pressing global health challenges today, affecting hundreds of millions of people and placing immense strain on healthcare systems worldwide. These conditions not only increase the risk of severe complications such as cardiovascular disease, kidney failure, and stroke but also significantly reduce quality of life and life expectancy. Addressing them requires urgent, coordinated action that integrates the latest scientific discoveries with practical clinical approaches and public health strategies. This congress matters because it fosters collaboration, innovation, and knowledge-sharing essential to reversing the rising tide of metabolic diseases and improving health outcomes for populations across the globe.
Impact and Takeaways
Attendees will gain:
- Insights into cutting-edge research and emerging therapies
- Practical strategies to improve clinical care and patient adherence
- Opportunities to network with global leaders and innovators
- A deeper understanding of public health approaches and policy development
- Tools to drive change in their own practice and communities
Sessions/Tracks
-
CRISPR-Edited Islet Cells for Type 1 Diabetes
-
Oral GLP-1 Receptor Agonists
-
Dual Incretin Agonists (GLP-1 + GIP)
-
Once-Weekly Insulin Therapies
-
GLP-1 Receptor Agonists for Cardiovascular & Renal Protection
-
Implantable Continuous Glucose Monitors (CGMs)
-
Automated Insulin Delivery Systems / Closed-Loop Pumps
-
Digital Twin Models for Personalized Diabetes Care
-
Continuous Ketone Monitoring for High-Risk Patients
-
AI & Machine Learning for Glucose Prediction and Diabetes Management
-
2025 ADA Standards of Care in Diabetes
-
Personalized Pharmacological Strategies
-
Evidence-Based Dietary Interventions
-
Real-World Evidence & Outcomes in Diabetes Treatment
-
Management of Comorbidities in Diabetes (Obesity, Hypertension, Dyslipidemia)
-
Global Targets & Strategies to Halt Diabetes Rise
-
Access to Affordable Insulin Worldwide
-
Diabetes Education & Awareness Programs
-
Innovations in Diabetes Care in Low-Resource Settings
-
Collaborative International Research in Diabetes
Important Dates
Abstract Submission Deadline
Date
May 15, 2026
Registration Deadline
Date
June 15, 2026
Full Paper Submission Deadline
Date
May 15, 2026
Event Venue
We will update soon !...
Advisory Committee
Testimonials
Media Partners